|
Found results for
patents
1.
|
Hepatitis C virus immunogenic compositions and methods of use thereof
Application Number |
18099035 |
Grant Number |
12042536 |
Status |
In Force |
Filing Date |
2023-01-19 |
First Publication Date |
2024-02-22 |
Grant Date |
2024-07-23 |
Owner |
- The Governors of the University of Alberta (Canada)
- Helmholtz Center for Infection Research (Germany)
|
Inventor |
- Houghton, Michael
- Landi, Abdolamir
- Guzman, Carlos A.
- Ebensen, Thomas
- Hockman, Darren
- Law, John L.
- Logan, Michael
|
Abstract
The present disclosure provides immunogenic compositions comprising: a) hepatitis C virus (HCV) E1E2 heterodimers, HCV E2, or HCV E1; and b) an adjuvant, where the adjuvant is a cyclic dinucleotide or an archaeosome. The present disclosure provides methods of inducing an immune response in an individual to HCV, the methods comprising administering to an individual an effective amount of an immunogenic composition of the present disclosure.
IPC Classes ?
- A61K 39/29 - Hepatitis virus
- A61K 39/00 - Medicinal preparations containing antigens or antibodies
- A61K 39/12 - Viral antigens
- A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A61P 31/14 - Antivirals for RNA viruses
- A61P 37/04 - Immunostimulants
- C01F 11/02 - Oxides or hydroxides
- C07D 323/00 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
- C07K 14/005 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from viruses
- C07K 14/18 - Togaviridae, e.g. flavivirus, pestivirus, yellow fever virus, hepatitis C virus, japanese encephalitis virus
- C07K 14/28 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Vibrionaceae (F)
- C07K 14/33 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Clostridium (G)
- C07K 14/34 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Corynebacterium (G)
- C12N 15/86 - Viral vectors
|
2.
|
Hepatitis C virus immunogenic compositions and methods of use thereof
Application Number |
16336732 |
Grant Number |
10881726 |
Status |
In Force |
Filing Date |
2017-10-05 |
First Publication Date |
2019-08-01 |
Grant Date |
2021-01-05 |
Owner |
- The Governors of the University of Alberta (Canada)
- Helmholtz Center for Infection Research (Germany)
|
Inventor |
- Houghton, Michael
- Landi, Abdolamir
- Guzman, Carlos A.
- Ebensen, Thomas
- Hockman, Darren
- Law, John L.
- Logan, Michael
|
Abstract
The present disclosure provides immunogenic compositions comprising: a) hepatitis C virus (HCV) E1E2 heterodimers, HCV E2, or HCV E1; and b) an adjuvant, where the adjuvant is a cyclic dinucleotide or an archaeosome. The present disclosure provides methods of inducing an immune response in an individual to HCV, the methods comprising administering to an individual an effective amount of an immunogenic composition of the present disclosure.
IPC Classes ?
- A61K 39/00 - Medicinal preparations containing antigens or antibodies
- A61K 39/12 - Viral antigens
- A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A61K 31/675 - Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A61K 39/095 - Neisseria
- A61K 39/29 - Hepatitis virus
- A61P 31/14 - Antivirals for RNA viruses
- A61P 37/04 - Immunostimulants
- C07K 14/005 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from viruses
- C01F 11/02 - Oxides or hydroxides
- C07D 323/00 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
- C07K 14/18 - Togaviridae, e.g. flavivirus, pestivirus, yellow fever virus, hepatitis C virus, japanese encephalitis virus
- C07K 14/28 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Vibrionaceae (F)
- C07K 14/33 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Clostridium (G)
- C07K 14/34 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Corynebacterium (G)
- C12N 15/86 - Viral vectors
|
3.
|
HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
Document Number |
03038810 |
Status |
Pending |
Filing Date |
2017-10-05 |
Owner |
- THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (Canada)
- HELMHOLTZ CENTER FOR INFECTION RESEARCH (Germany)
|
Inventor |
- Houghton, Michael
- Guzman, Carlos A.
- Ebensen, Thomas
- Landi, Abdolamir
|
Abstract
The present disclosure provides immunogenic compositions comprising: a) hepatitis C virus (HCV) E1E2 heterodimers, HCV E2, or HCV E1; and b) an adjuvant, where the adjuvant is a cyclic dinucleotide or an archaeosome. The present disclosure provides methods of inducing an immune response in an individual to HCV, the methods comprising administering to an individual an effective amount of an immunogenic composition of the present disclosure.
IPC Classes ?
- A61K 39/00 - Medicinal preparations containing antigens or antibodies
- A61K 39/29 - Hepatitis virus
- A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A61P 31/14 - Antivirals for RNA viruses
- A61P 37/04 - Immunostimulants
- C01F 11/02 - Oxides or hydroxides
- C07D 323/00 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
- C07K 14/18 - Togaviridae, e.g. flavivirus, pestivirus, yellow fever virus, hepatitis C virus, japanese encephalitis virus
- C07K 14/28 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Vibrionaceae (F)
- C07K 14/33 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Clostridium (G)
- C07K 14/34 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Corynebacterium (G)
|
|